We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00392184
First Posted: October 25, 2006
Last Update Posted: June 1, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Erlangen-Nürnberg Medical School
  Purpose
The purpose of this study is to determine whether accelerated partial breast irradiation (APBI) with multi-catheter brachytherapy is safe and effective.

Condition Intervention Phase
Breast Cancer Procedure: Accelerated partial breast irradiation Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery

Resource links provided by NLM:


Further study details as provided by University of Erlangen-Nürnberg Medical School:

Enrollment: 274
Study Start Date: November 2000
Study Completion Date: October 2010
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: APBI
Accelerated Partial Breast Irradiation with interstitial Brachytherapy
Procedure: Accelerated partial breast irradiation

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • pT1/2 (≤ 3 cm)
  • pN0 or pN1 mi
  • M0 and no contralateral BC
  • Clear margins (≥ 2 mm)
  • Age ≥ 35 years
  • ER and/or PR positive

Exclusion Criteria:

  • Multifocality or Multicentricity
  • EIC
  • Lymphovascular invasion
  • Poorly differentiated tumors
  • Diffuse microcalcifications
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00392184


Locations
Austria
Hospital Barmherzige Schwestern Linz
Linz, Austria
University Hospital AKH Vienna
Vienna, Austria, 1090
Germany
University Hospital Erlangen
Erlangen, Germany, 91052
University Hospital Leipzig
Leipzig, Germany, 04103
Sponsors and Collaborators
University of Erlangen-Nürnberg Medical School
Investigators
Study Chair: Vratislav Strnad, MD University Hospital Erlangen, Germany
Study Director: Oliver J Ott, MD University Hospital Erlangen, Germany
Principal Investigator: Guido Hildebrandt, MD University Hospital Leipzig, Germany
Principal Investigator: Richard Pötter, MD University Hospital AKH Vienna, Austria
Principal Investigator: Joe Hammer, MD Hospital Barmherzige Schwestern Linz, Austria
  More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier: NCT00392184     History of Changes
Other Study ID Numbers: German-Austrian APBI Trial
First Submitted: October 24, 2006
First Posted: October 25, 2006
Last Update Posted: June 1, 2015
Last Verified: May 2015

Keywords provided by University of Erlangen-Nürnberg Medical School:
accelerated partial breast irradiation
multicatheter brachytherapy
high dose rate brachytherapy
pulsed dose rate brachytherapy

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases